Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Fig 1.

Trial schedule for each patient.

MABG: Meta-astatobenzylguanidine, KI: Potassium iodine, 5-HT3: 5-hydroxytryptamine, ECOG PS: European comprehensive cancer group performance status, SpO2: Peripheral capillary oxygen saturation, MIBG: Meta-iodobenzylguanidine.

More »

Fig 1 Expand

Fig 2.

Structure of [211At] meta-astatobenzylguanidine (MABG).

More »

Fig 2 Expand

Table 1.

Dosage per level.

More »

Table 1 Expand

Fig 3.

Dose escalation method.

DLT: Dose limiting toxicity, MTD: Maximum tolerated dose, RD: Recommended dose.

More »

Fig 3 Expand